Cargando…
NUT Carcinoma—An Underdiagnosed Malignancy
NUT carcinoma (NC) is a rare and highly aggressive malignancy with a dismal prognosis and a median survival of 6–9 months only. Although very few cases of NC are reported each year, the true prevalence is estimated to be much higher, with NC potentially widely underdiagnosed due to the lack of aware...
Autores principales: | Lauer, Ulrich M., Hinterleitner, Martina, Horger, Marius, Ohnesorge, Paul V., Zender, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360329/ https://www.ncbi.nlm.nih.gov/pubmed/35957893 http://dx.doi.org/10.3389/fonc.2022.914031 |
Ejemplares similares
-
Long‐term remission of small cell lung cancer after reactivation of tuberculosis following immune‐checkpoint blockade: A case report
por: Sirgiovanni, Mattia, et al.
Publicado: (2021) -
Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma
por: Kloker, Linus D., et al.
Publicado: (2022) -
Myasthenia gravis as initial presentation of a pancreatic neuroendocrine tumor: A case report
por: Stingu, Elena, et al.
Publicado: (2023) -
Platelet-Expressed Synaptophysin (pSyn) as Novel Biomarker in Neuroendocrine Malignancies
por: Hinterleitner, Martina, et al.
Publicado: (2021) -
Inflammatory Surrogate Parameters for Predicting Ifosfamide-Induced Neurotoxicity in Sarcoma Patients
por: Schmidt, Moritz, et al.
Publicado: (2022)